POP-OUT | CLOSE

An Information Portal to 105212 Biological Macromolecular Structures

 
2-amino-2-deoxy-alpha-D-glucopyranose
 
PA1 is found in 8 entries
PA1
  •   Chemical Component Summary   Hide
    Name 2-amino-2-deoxy-alpha-D-glucopyranose
    Identifiers (2S,3R,4R,5S,6R)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol
    Formula C6 H13 N O5
    Molecular Weight 179.17 g/mol
    Type non-polymer
    Isomeric SMILES
    InChI
    InChI key MSWZFWKMSRAUBD-UKFBFLRUSA-N
     
  •   Drug Info: DrugBank Hide
    DrugBank ID DB01296   (Different stereochemistry)
    Name Glucosamine
    Groups approved
    Description Glucosamine is commonly used as a treatment for osteoarthritis, although its acceptance as a medical therapy varies. It is an amino sugar and a prominent precursor in the biochemical synthesis of glycosylated proteins and lipids. Since glucosamine is a precursor for glycosaminoglycans, and glycosaminoglycans are a major component of joint cartilage, supplemental glucosamine may help to rebuild cartilage and treat arthritis.
    Synonyms
    • 2-Amino-2-deoxy-D-glucose
    • Chitosamine
    • D-Glucosamine
    Mechanism of action Glucosamine is an amino sugar and a prominent precursor in the biochemical synthesis of glycosylated proteins and lipids. Oral glucosamine is commonly used for the treatment of osteoarthritis. Since glucosamine is a precursor for glycosaminoglycans, and glycosaminoglycans are a major component of joint cartilage, supplemental glucosamine may help to rebuild cartilage and treat arthritis. Its use as a therapy for osteoarthritis appears safe, but there is conflicting evidence as to its effectiveness with more recent studies showing limited to no clinical benefit of use. In the United States, glucosamine is not approved by the Food and Drug Administration for medical use in humans. Since glucosamine is classified as a dietary supplement, safety and formulation are solely the responsibility of the manufacturer; evidence of safety and efficacy is not required as long as it is not advertised as a treatment for a medical condition.
    CAS number 3416-24-8
    Targets
    Name Sequence search Pharmacological action Actions
    Matrix metalloproteinase-9   Search  yes antagonist
    Tumor necrosis factor   Search  unknown
    Interferon gamma   Search  unknown
    Chitosanase   Search  unknown
    Nuclear factor NF-kappa-B p100 subunit   Search  unknown antagonist
    [more]
     
Ligand Image